BioVaxys Technology Corp. (CSE:BIOV)

Canada · Delayed Price · Currency is CAD

0.0700

+0.0100 (16.67%)

May 5, 2026, 3:55 PM EST

BioVaxys Technology Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Cash & Equivalents	0	0.21	0	0.14	0.59	2.42
Cash & Short-Term Investments	0	0.21	0	0.14	0.59	2.42
Cash Growth	-99.17%	21579.22%	-99.31%	-76.08%	-75.52%	958.21%
Other Receivables	0.49	0.44	0.09	0.05	0.05	0.05
Receivables	0.49	0.44	0.09	0.21	0.13	0.05
Prepaid Expenses	0.9	0.65	0.02	0.36	0.15	0.59
Total Current Assets	1.39	1.3	0.11	0.71	0.87	3.06
Other Intangible Assets	-	-	-	-	7.4	7.4
Total Assets	1.39	1.3	0.11	0.87	8.5	10.46

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Accounts Payable	2.47	1.56	2.66	1.31	0.22	0.75
Accrued Expenses	2.42	1.6	0.83	0.33	0.11	0.15
Short-Term Debt	0.13	0.07	-	-	-	-
Total Current Liabilities	5.03	3.22	3.49	1.64	0.33	0.9
Total Liabilities	5.03	3.22	3.49	1.64	0.33	0.9

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Common Stock	28.59	27.04	21.99	17.05	14.76	10.75
Retained Earnings	-34.55	-31.25	-27.3	-19.61	-8.02	-1.56
Comprehensive Income & Other	2.32	2.29	1.93	1.78	1.44	0.37
Shareholders' Equity	-3.64	-1.92	-3.37	-0.77	8.18	9.56
Total Liabilities & Equity	1.39	1.3	0.11	0.87	8.5	10.46

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Total Debt	0.13	0.07	-	-	-	-
Net Cash (Debt)	-0.13	0.14	0	0.14	0.59	2.42
Net Cash Growth	-	14610.95%	-99.31%	-76.08%	-75.52%	958.21%
Net Cash Per Share	-0.00	0.01	0.00	0.01	0.07	0.86
Filing Date Shares Outstanding	29.15	29.15	22.02	11.53	9.97	8.15
Total Common Shares Outstanding	29.15	26.21	14.51	10.88	9.22	7.41
Working Capital	-3.64	-1.92	-3.37	-0.92	0.55	2.16
Book Value Per Share	-0.12	-0.07	-0.23	-0.07	0.89	1.29
Tangible Book Value	-3.64	-1.92	-3.37	-0.77	0.78	2.16
Tangible Book Value Per Share	-0.12	-0.07	-0.23	-0.07	0.08	0.29